Asthma phenotypes in children and stratified pharmacological treatment regimens

Maria Iordanidou1, Stelios Loukides2, Emmanouil Paraskakis1

  • 1a Paediatric Respiratory Unit, Department of Pediatrics , University Hospital of Alexandroupolis , Alexandroupolis , Greece.

Insights

Childhood asthma is complex, with multiple phenotypes influencing disease progression. Identifying these phenotypes is crucial for developing personalized treatment strategies and improving patient outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Childhood asthma is a prevalent inflammatory condition.
  • Genetic, environmental, and host factors interact to shape asthma's development, persistence, and severity.
  • Existing classifications of childhood asthma phenotypes are based on symptom onset, inflammation type, treatment response, and severity.

Purpose of the Study:

  • To review current childhood asthma phenotypes.
  • To discuss novel therapeutic strategies tailored to specific asthma phenotypes.
  • To emphasize the importance of phenotype identification for personalized pediatric asthma management.

Main Methods:

  • Literature review of current childhood asthma classifications.
  • Analysis of emerging therapeutic approaches for distinct asthma phenotypes.
  • Synthesis of expert commentary on phenotype-guided treatment.

Main Results:

  • Multiple distinct phenotypes exist in childhood asthma.
  • Phenotype identification is critical for effective treatment and prognosis.
  • Personalized therapeutic strategies are essential for managing diverse asthma presentations.

Conclusions:

  • Accurate classification of childhood asthma phenotypes is paramount before initiating personalized treatment.
  • Therapeutic strategies and monitoring must align with current clinical guidelines for optimal asthma care.
  • Understanding asthma heterogeneity is key to advancing pediatric respiratory medicine.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K